These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 28832656)
41. Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway. Ameen O; Samaka RM; Abo-Elsoud RAA Sci Rep; 2022 Oct; 12(1):17084. PubMed ID: 36224264 [TBL] [Abstract][Full Text] [Related]
42. Ginsenosides attenuate d-galactose- and AlCl Zhang Y; Pi Z; Song F; Liu Z J Ethnopharmacol; 2016 Dec; 194():188-195. PubMed ID: 27612432 [TBL] [Abstract][Full Text] [Related]
43. Acetylshikonin from Zicao attenuates cognitive impairment and hippocampus senescence in d-galactose-induced aging mouse model via upregulating the expression of SIRT1. Li Q; Zeng J; Su M; He Y; Zhu B Brain Res Bull; 2018 Mar; 137():311-318. PubMed ID: 29325995 [TBL] [Abstract][Full Text] [Related]
44. p-Coumaric acid protects against D-galactose induced neurotoxicity by attenuating neuroinflammation and apoptosis in mice brain. Daroi PA; Dhage SN; Juvekar AR Metab Brain Dis; 2022 Oct; 37(7):2569-2579. PubMed ID: 35913570 [TBL] [Abstract][Full Text] [Related]
45. Differential metformin dose-dependent effects on cognition in rats: role of Akt. Mostafa DK; Ismail CA; Ghareeb DA Psychopharmacology (Berl); 2016 Jul; 233(13):2513-24. PubMed ID: 27113224 [TBL] [Abstract][Full Text] [Related]
46. Neuronal marker recovery after Simvastatin treatment in dementia in the rat brain: in vivo magnetic resonance study. Tušková R; Lipták B; Szomolányi P; Vančová O; Uličná O; Sumbalová Z; Kucharská J; Dubovický M; Trattnig S; Liptaj T; Kašparová S Behav Brain Res; 2015 May; 284():257-64. PubMed ID: 25698600 [TBL] [Abstract][Full Text] [Related]
47. COMBINED TREATMENT WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN REDUCES INSULIN LEVELS BY INCREASED INSULIN CLEARANCE AND IMPROVES β-CELL FUNCTION. Ekholm E; Hansen L; Johnsson E; Iqbal N; Carlsson B; Chen H; Hirshberg B Endocr Pract; 2017 Mar; 23(3):258-265. PubMed ID: 27849380 [TBL] [Abstract][Full Text] [Related]
48. A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea. Moses RG; Kalra S; Brook D; Sockler J; Monyak J; Visvanathan J; Montanaro M; Fisher SA Diabetes Obes Metab; 2014 May; 16(5):443-50. PubMed ID: 24205943 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of the effect of thymoquinone in d-galactose-induced memory impairments in rats: Role of MAPK, oxidative stress, and neuroinflammation pathways and telomere length. Oskouei Z; Mehri S; Kalalinia F; Hosseinzadeh H Phytother Res; 2021 Apr; 35(4):2252-2266. PubMed ID: 33325602 [TBL] [Abstract][Full Text] [Related]
50. Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease. Siddiqui N; Ali J; Parvez S; Zameer S; Najmi AK; Akhtar M Neuropharmacology; 2021 Sep; 195():108662. PubMed ID: 34119519 [TBL] [Abstract][Full Text] [Related]
51. Isorhynchophylline improves learning and memory impairments induced by D-galactose in mice. Xian YF; Su ZR; Chen JN; Lai XP; Mao QQ; Cheng CH; Ip SP; Lin ZX Neurochem Int; 2014 Oct; 76():42-9. PubMed ID: 24984171 [TBL] [Abstract][Full Text] [Related]
52. The effects of valsartan on cognitive deficits induced by aluminum trichloride and d-galactose in mice. Yang WN; Hu XD; Han H; Shi LL; Feng GF; Liu Y; Qian YH Neurol Res; 2014 Jul; 36(7):651-8. PubMed ID: 24620968 [TBL] [Abstract][Full Text] [Related]
53. Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats. Pintana H; Apaijai N; Pratchayasakul W; Chattipakorn N; Chattipakorn SC Life Sci; 2012 Oct; 91(11-12):409-414. PubMed ID: 22925597 [TBL] [Abstract][Full Text] [Related]
55. Salidroside suppresses inflammation in a D-galactose-induced rat model of Alzheimer's disease via SIRT1/NF-κB pathway. Gao J; Zhou R; You X; Luo F; He H; Chang X; Zhu L; Ding X; Yan T Metab Brain Dis; 2016 Aug; 31(4):771-8. PubMed ID: 26909502 [TBL] [Abstract][Full Text] [Related]
56. Combined administration of D-galactose and aluminium induces Alzheimer-like lesions in brain. Xiao F; Li XG; Zhang XY; Hou JD; Lin LF; Gao Q; Luo HM Neurosci Bull; 2011 Jun; 27(3):143-55. PubMed ID: 21614097 [TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: a randomized controlled trial. Yang W; Pan CY; Tou C; Zhao J; Gause-Nilsson I Diabetes Res Clin Pract; 2011 Nov; 94(2):217-24. PubMed ID: 21871686 [TBL] [Abstract][Full Text] [Related]
58. Piperine regulates glycogen synthase kinase-3β-related signaling and attenuates cognitive decline in D-galactose-induced aging mouse model. Wang C; Cai Z; Wang W; Wei M; Si X; Shang Y; Yang Z; Li T; Guo H; Li S J Nutr Biochem; 2020 Jan; 75():108261. PubMed ID: 31710934 [TBL] [Abstract][Full Text] [Related]
59. Caffeic acid attenuates oxidative stress, learning and memory deficit in intra-cerebroventricular streptozotocin induced experimental dementia in rats. Deshmukh R; Kaundal M; Bansal V; Samardeep Biomed Pharmacother; 2016 Jul; 81():56-62. PubMed ID: 27261577 [TBL] [Abstract][Full Text] [Related]
60. Protective effect of metformin on D-galactose-induced aging model in mice. Fatemi I; Khaluoi A; Kaeidi A; Shamsizadeh A; Heydari S; Allahtavakoli MA Iran J Basic Med Sci; 2018 Jan; 21(1):19-25. PubMed ID: 29372032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]